Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling
about
Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic DiseasesResveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signalingChronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice.Perivascular fat, AMP-activated protein kinase and vascular diseases.mTOR inhibitors as a new therapeutic option for epilepsy.Effects of resveratrol and nebivolol on isolated vascular and cardiac tissues from young rats.The role and potential mechanism of resveratrol in the prevention and control of epilepsy.Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma.Effects of resveratrol on the treatment of inflammatory response induced by severe burn.Resveratrol for Easing Status Epilepticus Induced Brain Injury, Inflammation, Epileptogenesis, and Cognitive and Memory Dysfunction-Are We There Yet?Evaluation of metformin effects in the chronic phase of spontaneous seizures in pilocarpine model of temporal lobe epilepsy.Resveratrol ameliorates ionizing irradiation-induced long-term immunosuppression in mice.Beneficial Effects of Resveratrol-Mediated Inhibition of the mTOR Pathway in Spinal Cord Injury.
P2860
Q28069705-1C80937E-E8F2-4ACC-8E5C-4E7265B41694Q35080161-231E8B97-F071-4099-A3D0-0C5B7D98B2B2Q37137264-C0E2579E-85BD-49C8-93F6-7B63022B4FB8Q37671282-8E350DC5-D26F-4ABF-A906-0095C559465AQ38112211-23A2D3E5-F70F-4E00-9D94-BA86E78189EBQ38256443-A6AFDE77-5714-4323-BA7A-EA4E7B38FA48Q38617173-EE082328-0829-4053-9DAD-4BCDB5922F4AQ38966954-47E1F3FA-4BF2-42D6-BE69-D3BAAFFDD672Q41546329-70D41D89-0C8B-432B-9AB4-1C3EB9A4088AQ46550304-5E59AF18-FC7C-4DB3-9D9F-F77FB2189D38Q47401760-47867938-1D71-44A2-88F6-0A2309460785Q48217931-437B5EA9-CBD3-4756-A09F-567EF18995CCQ55018726-5B6646D1-6DFA-469C-9ADD-8302A933460B
P2860
Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling
description
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2013
@ast
im Januar 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2013/01/25)
@sk
vědecký článek publikovaný v roce 2013
@cs
wetenschappelijk artikel (gepubliceerd op 2013/01/25)
@nl
наукова стаття, опублікована в січні 2013
@uk
مقالة علمية (نشرت في 25-1-2013)
@ar
name
Resveratrol pre-treatment redu ...... epilepticus via mTOR signaling
@ast
Resveratrol pre-treatment redu ...... epilepticus via mTOR signaling
@en
Resveratrol pre-treatment redu ...... epilepticus via mTOR signaling
@nl
type
label
Resveratrol pre-treatment redu ...... epilepticus via mTOR signaling
@ast
Resveratrol pre-treatment redu ...... epilepticus via mTOR signaling
@en
Resveratrol pre-treatment redu ...... epilepticus via mTOR signaling
@nl
prefLabel
Resveratrol pre-treatment redu ...... epilepticus via mTOR signaling
@ast
Resveratrol pre-treatment redu ...... epilepticus via mTOR signaling
@en
Resveratrol pre-treatment redu ...... epilepticus via mTOR signaling
@nl
P2093
P3181
P1433
P1476
Resveratrol pre-treatment redu ...... epilepticus via mTOR signaling
@en
P2093
Sheng-Jun Wang
Xiu-He Zhao
Xue-Wu Liu
Zhao-Fu Chi
P304
P3181
P356
10.1016/J.BRAINRES.2012.11.027
P407
P577
2013-01-25T00:00:00Z